[1] LIU M,LIU S W,WANG L J,et al.Burden of diabetes,hyperglyca-emia in China from to 2016:findings from the 1990 to 2016, Global Burden of Disease study[J].Diabetes Metab,2019,45(3):286-293. [2] GBD 2015 Obesity Collaborators,AFSHIN A,FOROUZANFAR M H,et al.Health effects of overweight and obesity in 195 countries over 25 years[J].N Engl J Med,2017,377(1):13-27. [3] LEE J J,BERETVAS S N,FREDDLAND-GRAVES J H.Abdominal adiposity distribution in diabetic/prediabetic and nondiabetic populations: a meta-analysis[J]. J Obes,2014:697264. [4] HOU X,CHEN S,HU G,et al .Stronger associations of waist circumference and waist-to-height ratio with diabetes than BMI in Chinese adults[J].Diabetes Res Clin Pract,2019,147:9-18. [5] JURIS J M,BJOERN A M,THOMAS G K,et al.Functional assess- ment of pancreatic β-cell area in humans[J].Diabetes,2009,58(7):1595-1603. [6] OHN J H,KWAK S H,CHO Y M,et al.10-year trajectory of β-cell function and insulin sensitivity in the development of type 2 diabetes:a community-based prospective cohort study[J].Lancet Diabetes Endocrinol,2016,4(1):27-34. [7] DEFRONZO R A.From the triumvirate to the ominous octet: anewparadi-gmfor the treatment of type 2 diabetes[J].Diabetes,2009,58(4):773-795. [8] SAISHO Y.Postprandial C-peptide to glucose ratio as a marker of β cell function: implication for the management of type 2 diabetes[J].Int J Mol Sci,2016,17(5):744. [9] 中国高血压防治指南修订委员会高血压联盟(中国),中华医学会心血管病学分会,中国医师协会高血压专业委员会,等.中国高血压防治指南(2018年修订版)[J].中国心血管杂志,2019,24(1):24-56. [10] 中国成人血脂异常防治指南修订联合委员会.中国成人血脂异常防治指南(2016年修订版)[J].中华心血管病杂志,2016(10):833-853. [11] BARAZZONI R,GORTAN CAPPELLARI G,RAGNI M,et al.Insulin resistance in obesity: an overview of fundamental alterations[J].Eat Weight Disord,2018,23(2):149-157. [12] PANH S J, MAN Q Q, SONG S,et al.Relationships of insulin action to age, gender, body mass index, and waist circumference present diversely in different glycemic statuses among Chinese population[J].J Diabetes Res,2018,23:1682959. [13] KABADI U M.Major Pathophysiology in prediabetes and type 2 diabetes:decreased insulin in lean and insulin resistance in obese[J].J Endocr Soc,2017,1(6):742-750. [14] BJORNSTAD P,ECKEL R H.Pathogenesis of lipid disorders in insu-lin resistance: a brief review[J].Curr Diab Rep,2018,18(12):127. [15] ERGMAN R N,ADERR M,HUECKING K,et al.Accurate assess-ment ofbeta-cell function: the hyperbolic correction[J].Diabetes,2002,51(Suppl.1):S212-220. |